Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial
- First Online:
Cancer patients often experience diminished cognitive function (CF) and quality of life (QOL) due to the side effects of treatment and the disease symptoms. This study evaluates the effects of medical Qigong (MQ; combination of gentle exercise and meditation) on CF, QOL, and inflammation in cancer patients.
Eighty-one cancer patients recruited between October 2007 and May 2008 were randomly assigned to two groups: a control group (n = 44) who received the usual health care and an intervention group (n = 37) who participated in a 10-week MQ program. Self-reported CF was measured by the European Organization for Research and Treatment of Cancer (EORTC-CF) and the Functional Assessment of Cancer Therapy—Cognitive (FACT-Cog). The Functional Assessment of Cancer Therapy—General (FACT-G) was used to measure QOL. C-reactive protein (CRP) was assessed as a biomarker of inflammation.
The MQ group self-reported significantly improved CF (mean difference (MD) = 7.78, t51 = −2.532, p = 0.014) in the EORTC-CF and all the FACT-Cog subscales [perceived cognitive impairment (MD = 4.70, t43 = −2.254, p = 0.029), impact of perceived cognitive impairment on QOL (MD = 1.64, t45 = −2.377, p = 0.024), and perceived cognitive abilities (MD = 3.61, t45 = −2.229, p = 0.031)] compared to controls. The MQ group also reported significantly improved QOL (MD = 12.66, t45 = −5.715, p < 0.001) and had reduced CRP levels (MD = −0.72, t45 = 2.092, p = 0.042) compared to controls.
Results suggest that MQ benefits cancer patients’ self-reported CF, QOL, and inflammation. A larger randomized controlled trial including an objective assessment of CF is planned.
KeywordsCancer Cognitive function Quality of life Inflammation Medical Qigong
- 10.Vardy J, Xu W, Booth C et al (2008) Relation between perceived cognitive function and neuropsychological performance in survivors of breast and colorectal cancer. ASCO Meeting Abstracts, p 9520Google Scholar
- 15.Vardy J (2009) Cognitive function in survivors of cancer. ASCO Educational Book 2009(1):570–574Google Scholar
- 32.Wagner L, Sweet J, Butt Z et al (2009) Measuring patient self-reported cognitive function: development of the Functional Assessment of Cancer Therapy—Cognitive Function instrument. J Support Oncol 7(6):W32–W39Google Scholar
- 35.Carlson LE, Speca M, Patel KD et al (2004) Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 29(4):448–474PubMedCrossRefGoogle Scholar
- 40.Luo S, Tong T (1988) Effect of vital gate Qigong exercise on malignant tumor. First World Conference for Academic Exchange of Medical Qigong, Beijing, p 122Google Scholar